SCHEMBL14367140

SCHEMBL14367140

Cc1cc(C(=O)Nc2ccc([N+](=O)[O-])cc2)no1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 8/20 0.69
▸ RAB9A P51151 8/20 0.69
▸ ALDH1A1 P00352 4/20 0.69
▸ TP53 P04637 2/20 0.69
▸ GLA P06280 1/20 0.69
▸ HTT P42858 1/20 0.69
▸ SMN1; SMN2 Q16637 4/20 0.63
▸ NFKB1 P19838 1/20 0.63
▸ NFKB2 Q00653 1/20 0.63
▸ RELA Q04206 1/20 0.63
▸ MAPT P10636 4/20 0.56
▸ POLB P06746 2/20 0.56
▸ USP2 O75604 1/20 0.56
▸ HSD17B10 Q99714 1/20 0.54
▸ LMNA P02545 1/20 0.52
▸ GAA P10253 1/20 0.52
▸ MEN1 O00255 3/20 0.52
▸ KMT2A Q03164 3/20 0.52
▸ MITF O75030 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8267173 0.87 NPC1 (0.90) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL8267406 0.85 MEN1 (0.72) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL25235561 0.83 MAPT (0.67) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL25206621 0.83 ALDH1A1 (0.59) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL10192186 0.82 NPC1 (1.00) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL8267152 0.81 NPC1 (0.79) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL13321363 0.81 RAB9A (0.79) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL8266861 0.80 NPC1 (0.77) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL8266868 0.79 RAB9A (0.77) NPC1RAB9AALDH1A1TP53GLA
SCHEMBL1394901 0.78 NPC1 (0.75) NPC1RAB9AALDH1A1TP53GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7291743-B2 Isoxazole derivatives and methods of treating nitric oxide mediated diseases GENEBLUE CORPORATION (US) 2007-11-06 — — US disclosed
US-7291743-B2 Isoxazole derivatives and methods of treating nitric oxide mediated diseases GENEBLUE CORPORATION (US) 2007-11-06 — — US disclosed
Send feedback